Introduction Intertransverse posterolateral fusion along with instrumentation is a common technique used for spinal fusion. Iliac crest bone graft (ICBG) oVers good fusion success rates with a low risk for disease transmission but is, however, linked with certain morbidity. In an eVort to eliminate or reduce the amount of iliac graft needed, bone substitutes including demineralized bone matrix (DBM) have been developed. This study evaluates a novel DBM (Accell Connexus ® ) used in one or two-level instrumented posterolateral lumbar fusion. Materials and methods A total of 59 consecutive patients were studied as two groups. Group 1 consisted of 33 patients having Accell Connexus ® used to augment either ICBG or local decompression material. Group 2 consisted of 26 consecutive patients, operated prior to the introduction of this novel DBM, having either ICBG alone or local decompression material. Fusion was assessed by two independent observers, blinded to graft material, using standardized criteria found in the literature. All adverse events were recorded prospectively. Results The results show no statistically signiWcant diVerences between the two groups in fusion rates, complications, surgery duration, ODI, or pain on VAS. Logistical regression showed no relation between fusion and age, smoking status or comorbidities. Furthermore, no adverse events related to the use of the novel DBM were observed. Conclusion The results from this study demonstrate that the novel DBM presented performs equally as well as that of autologous bone, be it either ICBG or a local decompression material, and can therefore be used as a graft extender.
Introduction
Spinal fusion is one of the most common procedures performed in spinal surgery, with more than 200,000 annual cases performed in the United States alone [2] . Intertransverse posterolateral fusion (PLF) along with instrumentation is one of the common techniques used in spinal fusion and the osseous repair procedure where the most bone graft material is used. From the many bone-grafting options available, iliac crest bone graft (ICBG) remains the most popular. ICBG oVers good success rates and low risk for disease transmission [10] . Harvesting of ICBG is nevertheless linked with certain morbidity. Reported complications include hematoma, false aneurysm, nerve and arterial injuries [5, 13, 17] , gait disturbances, fractures of the iliac wing [7, 11, 15, 16] , visceral and ureteral injuries [8, 14] , peritoneal perforation, infections [13] , sacroiliac instability, and pain [13] . In particular, residual pain has been reported to occur in as much as 31% of the cases [9] .
In an eVort to reduce the amount of iliac graft needed, several bone substitutes have been developed. Demineralized bone matrix (DBM) is one of these because it has been shown that properly demineralized cortical bone preserves the natural capacity of the native bone proteins and growth factors [22] . Although initial DBMs contained glycerol as a carrier for the DBM particles, this substance has been found to be detrimental for host cells and nephrotoxic at high doses [3, 23] and can migrate within the site or upon irrigation due to the water solubility of the carrier. Newer DBMs are therefore being developed with improved carrier composition and increased matrix induction concentration. Studies based on Wrst generation DBMs are available in the literature [4, 19] . To our knowledge however, there are no clinical studies available on the safety and eYcacy of these newer generation DBMs for spinal fusion.
The objective of this pilot study was to evaluate the clinical and radiological performance of a novel DBM (Accell Connexus ® ) composed of a DBM-based carrier with a reverse phase copolymer additive (IsoTis OrthoBiologics Inc., Irvine, CA, USA) used as a graft extender in one or two-level instrumented posterolateral lumbar fusion.
Materials and methods
A total of 59 consecutive patients (22 males and 37 females) were included in the study. All the patients underwent one-or two-level instrumented intertransverse fusion. Diagnosis included lumbar spinal stenosis with spondylolisthesis (n = 37), degenerative disc disease (n = 11), lumbar fractures (n = 2), and isthmic spondylolisthesis (n = 9); 40 patients had one-level fusion and the remaining 19 had two-level fusion. The patients were organized in two groups. Group 1 comprised 33 consecutively operated patients (average age of 64.6 years) in whom 2.5-10 cm 3 of Accell Connexus ® putty combined with an autologous bone marrow aspirate from the iliac crest was used to augment either ICBG, or a local decompression material, in a standardized ratio as per the manufacturer's recommendations (1:1 with 5 cm 3 of bone marrow). This ratio is aimed at obtaining adequate containment of all the autograft particles while maximizing the inductive potential provided as a stimulus to the native osteogenic autograft and is considered as the right balance for this purpose in the absence of studies on the subject. The addition of the reverse phase copolymer to the DBM-based substance allows for composite graft containment and the ability to irrigate once placed. The control group (Group 2) consisted of 26 consecutive patients (average age of 58.3 years) operated on prior to the introduction of Accell Connexus ® in our institution. ICBG alone, or local decompression material, was used for these patients. In both the groups the grafting material was placed posterolateraly over the transverse processes or lateral mass of the sacrum following decortication. All the patients received rigid titanium 6 mm polyaxial pedicle screws originating from the same manufacturer (Expedium, DePuy Spine Inc., Raynham, MA, USA). Age, distribution of the type of diagnosis, and the number of two-level fusions performed, were similar for both the groups. All the patients were treated by the same senior surgeon (CS) in one institution. Prophylactic antibiotics and low molecular weight heparin were used by all the patients. Non-steroidal anti-inXammatory drugs (NSAIDs) were proscribed during the Wrst 3 months for both the patient groups. A soft orthosis was used in all patients for the Wrst 6 weeks following surgery. The proportion of smokers was 27 and 34% for groups 1 and 2, respectively. Patients were followed up clinically and radiologically, at 6 weeks, and at 3, 6 and 12 months post surgery. No patient from either group was lost to follow-up. Ethical committee approval was obtained by the institutional review board and all patients gave their informed consent.
Radiographically, the Christensen et al. fusion criteria for union [6] were applied to study plain X-rays taken at 12 months. According to this classiWcation, "fusion" indicates qualitative fusion at all intended levels (Figs. 1, 2) . Suboptimal quality or a fusion mass hidden by instrumentation is to be counted as "non-fusion". The clinical outcome measures employed were the Oswestry disability index Grafting consisted of decompression material and DBM. The entire graft mass is not readily observed as the DBM is not radiopaque (ODI) and pain assessed using the visual analogue scale (VAS), given preoperatively and one year post-surgery.
Two independent observers, blinded to the type of graft material, assessed the Wlms for the presence of bridging bone between the transverse processes using a consensus interpretation. All adverse events and complications were recorded prospectively for both groups. Statistical analyses were performed utilizing Fisher's exact two-tailed test, Student's unpaired t test and a logistic regression.
Results
No signiWcant diVerence (P = 0.86) was found between operating times for group 1 (average = 241 min) and group 2 (average = 244 min). No deep infections occurred in either group. Furthermore, no adverse event related to the use of DBM was noted. In particular, no intraoperative hypotension or allergic reaction was registered. One patient from each group suVered a pulmonary embolus recovering uneventfully following appropriate treatment. There were two dural tears in group 1 and one in group 2, both treated with primary repair, and resulting in no long-term consequences.
Fusion was found in 23 out of the 33 (69.7%) patients from group 1, and 20 out of the 26 (76.9%) patients from group 2. This diVerence was not statistically signiWcant (Table 1 ). In addition, subgroup analyses showed no signiWcant diVerence (P = 0.77) in fusion rates between patients receiving decompression material alone or those augmented with ICBG. Furthermore, there was no statistical diVerence in the preoperative VAS and ODI or in their improvement reported at one year post-surgery between the two groups. Average values and levels of signiWcance can be found in Table 1 . No implant failure was observed in either group.
Results from a logistic regression analysis showed no relation between the occurrence of radiological fusion and age, smoking status, comorbidities, length of surgery, volume of DBM, or pain (VAS) and function (ODI) reported at 1 year.
Discussion
This study focuses on the safety and eYcacy of a new DBM-based osteoinductive bone graft material used as a graft extender in one-or two-level posterolateral instrumented lumbar fusion. Several studies, reviewed and summarized by Lee at al. [18] , have been carried out using various animal models and DBM preparations to demonstrate diVerences in fusion rates based on several factors including the DBM formulation, and the animal model used. Fewer studies, however, can be currently found in the literature covering the use of DBM in a human clinical population. Studies have evaluated previous generation DBMs (Grafton) for posterolateral lumbar fusion [4, 12, 20, 21] . From these studies, one showed lower fusion rates using coralline hydroxyapatite with the addition of DBM [21] , and the others demonstrated the utility of DBMs as graft extenders but not as fusion enhancers [4, 12, 20] . The fusion rates in the present study are lower than those commonly cited and tacitly accepted (approaching 90%) for instrumented posterolateral fusion using autologous ICBG. Camissa et al. [4] , in their study on the use of Grafton, also noted relatively lower rates (65%) which they ascribed to a very diYcult to manage patient population, very strict radiographic criteria and the need to evaluate the graft visible lateral to the instrumentation. The latter in our opinion, may have contributed to some extent in our study as well, with the other two reasons being more diYcult to quantify. Indeed evaluating graft visibility lateral to the instrumentation may underestimate the true fusion rates. It could be that if more autologous graft volume is used (e.g., from minced local bone), and if rods are more medially placed, the visibility of the fusion mass would be enhanced without necessarily increasing the fusion rate. It is interesting to note that in our department the revision rate for pseudarthrosis is less than 1% for patients treated in exactly the same manner prior to the beginning of the present study, albeit without the use of DBM.
The use of plain radiographs presents a limitation in assessing fusion when compared to the suggested improved accuracy observed from the use of computed tomography (CT) images. Using CT images however, subjects patients to increased amounts of radiation which we found an unnecessary risk considering the simplicity and good interand intra-observer agreement [6] reported for the radiological criteria chosen.
An added caveat to the results presented, is the shorter than 2 years follow-up period as has been previously suggested [1] . We did nevertheless succeed in obtaining a 100% 1 year follow up chieXy through the excellent compliance of our patient population. In addition, this study was not randomized but consisted of a consecutive series of patients before and after the availability of the aforementioned DBM in our institution. The study beneWts from being performed at a single institution by the same operating surgeon eliminating possible technical diVerences such as graft harvesting and preparation of the graft bed.
In summary, the results of this study demonstrate the role of this novel DBM as a safe and eVective graft extender in one or two level posterolateral instrumented fusion at 1 year post-surgery. The composition is also eVective in containing the graft within the surgical site, resisting irrigation. More clinical studies using recommended designs are needed to further evaluate newer generation DBMs and more discriminating techniques, such as CT scans, should be considered to better assess the progression of fusion.
